Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Abivax ADR (NASDAQ: ABVX) was $6.43 for the day, down -18.71% from the previous closing price of $7.91. In other words, the price has decreased by -$18.71 from its previous closing price. On the day, 1.24 million shares were traded.
Ratios:
Our analysis of ABVX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.04 and its Current Ratio is at 3.04. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.48.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on December 04, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $33.
On July 29, 2024, Laidlaw started tracking the stock assigning a Buy rating and target price of $48.
On May 20, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $43.BTIG Research initiated its Buy rating on May 20, 2024, with a $43 target price.
Stock Price History:
Over the past 52 weeks, ABVX has reached a high of $17.02, while it has fallen to a 52-week low of $5.49. The 50-Day Moving Average of the stock is -6.25%, while the 200-Day Moving Average is calculated to be -36.68%.
Shares Statistics:
A total of 62.92M shares are outstanding, with a floating share count of 55.12M. Insiders hold about 13.02% of the company’s shares, while institutions hold 35.67% stake in the company.
